Home › NDC Lookup › RxCUI directory › RxCUI 242680

Abacavir 20 MG/ML Oral Solution — RxCUI 242680

RxNorm drug concept · Semantic clinical drug
RxCUI 242680 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI242680
Official nameAbacavir 20 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asabacavir (as abacavir sulfate) 20 MG per 1 ML Oral Solution; abacavir 20 MG in 1 mL Oral Solution
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)145 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Abacavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Abacavir works by blocking a key step HIV uses to copy itself inside your cells. But HIV is clever — if you use just one medicine, the virus can mutate and find a workaround. Using...
  • What exactly does abacavir do, and why do I have to take it with other HIV medicines?
  • Yes, and this one is really important. Before you start abacavir, your doctor will test you for a gene variant called HLA-B*5701. People who carry this variant are at much higher r...
  • I heard there's a genetic test I need before starting — what is that about?
📖 Read our full Abacavir guide →

🕸️ Concept Web — How Abacavir 20 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Abacavir 20 MG/ML Oral Solution RxCUI 242680

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Abacavir 190521
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ziagen 221017
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Abacavir Oral Solution 370502
    • Abacavir Oral Liquid Product 1163062
    • Abacavir Oral Product 1163063
    • Abacavir Oral Solution [Ziagen] 364596
    • Ziagen Oral Liquid Product 1187454
    • Ziagen Oral Product 1187455
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Abacavir 20 MG/ML SCDC · 329484
  • Abacavir Oral Solution SCDF · 370502
  • Abacavir Oral Liquid Product SCDG · 1163062
  • Abacavir Oral Product SCDG · 1163063

Brand-Name Concepts

  • Abacavir 20 MG/ML Oral Solution [Ziagen] SBD · 213461
  • Abacavir 20 MG/ML [Ziagen] SBDC · 573349
  • Abacavir Oral Solution [Ziagen] SBDF · 364596
  • Ziagen Oral Liquid Product SBDG · 1187454
  • Ziagen Oral Product SBDG · 1187455
  • Ziagen BN · 221017

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 242680 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0562-24 240 mL in 1 BOTTLE (31722-562-24) Abacavir Camber Pharmaceuticals, Inc. 2016-09-26
49702-0222-48 1 BOTTLE in 1 CARTON (49702-222-48) / 240 mL in 1 BOTTLE ZIAGEN ViiV Healthcare Company 1999-01-28
64980-0405-24 1 BOTTLE in 1 CARTON (64980-405-24) / 240 mL in 1 BOTTLE Abacavir Rising Pharma Holdings, Inc. 2018-03-14
65862-0089-24 1 BOTTLE in 1 CARTON (65862-089-24) / 240 mL in 1 BOTTLE Abacavir Aurobindo Pharma Limited 2018-03-14
Observed labelers: Aurobindo Pharma Limited (1) · Camber Pharmaceuticals, Inc. (1) · Rising Pharma Holdings, Inc. (1) · ViiV Healthcare Company (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.